By Rachel Moss
One in five ovarian cancer patients is too ill to treat by the time she receives her diagnosis, according to new data.
The charity Target Ovarian Cancer warned that delays in diagnosis are common and leave too … Read more
By
Researchers have discovered a curious difference between the DNA from cancer cells and that from healthy cells, and this finding could lead to a new blood test for cancer.
The difference? Cancer DNA has a … Read more
By Beth Miller
Researchers have found an innovative way to use sound and light, or photoacoustic, imaging to diagnose ovarian tumors. The method may lead to a promising new diagnostic imaging technique to improve current standard of care for patients … Read more
By Korin Miller
Here’s what to know—and how to try to protect yourself.
Finding out that you or someone you love has any kind of cancer is disorienting, frightening, and generally a hellish experience. This is pretty typical no matter … Read more
Cancer patients could be spared unnecessary chemotherapy – and its side effects – by a new blood test that is in clinical trials at more than 40 hospitals in Australia and New Zealand.
The trials, led by Melbourne researchers, are … Read more
By Diane Mapes
Despite its long-standing nickname, ovarian cancer isn’t really a silent killer. There are symptoms; it’s just that they whisper or are commonly mistaken for something else, like aging or irritable bowel syndrome. As a result of this
Lawsuits didn’t do it, public shaming didn’t do it, patients and doctors banding together to “free the data” couldn’t do it: For 22 years Myriad Genetics, one of the oldest genetic testing companies, has refused to make … Read more
By Health Day News
Testing for gene mutations linked to breast and ovarian cancer is rare among some Medicare patients who have the cancers and qualify for such tests, a new study finds.
Researchers analyzed data from 12 southeastern states … Read more
A sample obtained from routine Papanicolaou (Pap) tests used for cervical cancer screening can be subjected to a multiplex panel test, dubbed PapSEEK, to determine whether the sample is positive for endometrial or ovarian cancer, two gynecologic cancers for which … Read more
The U.S. government said on Friday it will pay for certain genetic tests for Medicare-eligible patients with advanced cancer, in a bid to help match patients with the drugs most likely to provide benefit.
The Centers for Medicare & Medicaid … Read more
As genetic testing becomes more accessible with advanced technology and decreased costs, population-based testing for breast and ovarian cancer may be more cost effective in the long run, according to study results published in Journal of the National Cancer Institute… Read more
Evidence is growing that all women age 30 and older should be tested for the inherited gene mutations that can cause breast and ovarian cancer, according to British researchers.
“We could prevent thousands more ovarian and breast cancers through a … Read more
I had a family member who was diagnosed with late stage ovarian cancer 20 years ago and died of the disease at the age of 47. Even though her symptoms appeared a year before her diagnosis with abdominal bloating, indigestion, … Read more
A new version of a screening test for ovarian cancer may reduce deaths from the disease, but it needs more study to determine whether the benefits hold up, researchers reported on Thursday.
The findings come from a 14-year study of … Read more
Suppose the mammography had never been invented—how much would we know today about breast cancer? Without it, how many more women might have died from breast cancer? Unlike mammography, no routine test, such as a Pap smear, can yet detect … Read more
Starting
January 1, 2025,
Clearity is joining
Ovarian Cancer
Research Alliance
(OCRA) and this website
will be redirected to
www.ocrahope.org
OCRA and Clearity are committed to serving the ovarian cancer community and providing the education, information, and support people need.
